AI assistant
IMPINJ INC — Director's Dealing 2024
Jun 18, 2024
30994_dirs_2024-06-18_c05ff85e-37f1-42a9-8a0a-dd1e29fb93f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMPINJ INC (PI)
CIK: 0001114995
Period of Report: 2024-06-15
Reporting Person: DIORIO CHRIS PH.D. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-15 | Common Stock | M | 1563 | — | Acquired | 287793 | Direct |
| 2024-06-17 | Common Stock | S | 272 | $149.5617 | Disposed | 287521 | Direct |
| 2024-06-17 | Common Stock | S | 344 | $150.2753 | Disposed | 287177 | Direct |
| 2024-06-17 | Common Stock | M | 5000 | $22.40 | Acquired | 292177 | Direct |
| 2024-06-17 | Common Stock | S | 1815 | $147.9302 | Disposed | 290362 | Direct |
| 2024-06-17 | Common Stock | S | 2933 | $148.7943 | Disposed | 287429 | Direct |
| 2024-06-17 | Common Stock | S | 252 | $149.5108 | Disposed | 287177 | Direct |
| 2024-06-18 | Common Stock | M | 5000 | $22.40 | Acquired | 292177 | Direct |
| 2024-06-18 | Common Stock | S | 4999 | $150.9231 | Disposed | 287178 | Direct |
| 2024-06-18 | Common Stock | S | 1 | $152.08 | Disposed | 287177 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-15 | Restricted Stock Units | $0 | M | 1563 | Disposed | Common Stock (1563) | Direct | |
| 2024-06-17 | Stock Option (right to buy) | $22.40 | M | 5000 | Disposed | 2028-06-15 | Common Stock (5000) | Direct |
| 2024-06-18 | Stock Option (right to buy) | $22.40 | M | 5000 | Disposed | 2028-06-15 | Common Stock (5000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 552494 | Indirect |
Footnotes
F1: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units ("RSUs").
F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $148.8801 to $149.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F3: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $149.90 to $150.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F4: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024.
F5: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $147.39 to $148.37, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F6: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $148.40 to $149.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F7: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $149.505 to $149.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F8: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $150.70 to $151.655, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F9: Each RSU represents a contingent right to receive one share of Impinj common stock.
F10: On June 15, 2020, the reporting person was granted 25,000 RSUs, one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on June 15, 2024.
F11: The option became fully vested on June 11, 2022.